459
$50M$100M
966$100M$1B
192$10M$50M
145$10M$50M
413$50M$100M
114$10M$50M
11
732$100M$1B
201$50M$100MPeloton Therapeutics uses 8 technology products and services including Google Cloud CDN, RequireJS, Lodash, and more. Explore Peloton Therapeutics's tech stack below.
| Peloton Therapeutics Email Formats | Percentage |
| First.Last@pelotontx.com | 62% |
| Last@pelotontx.com | 38% |
| First.Last@pelotontherapeutics.com | 33% |
| FLast@pelotontherapeutics.com | 23% |
| First@pelotontherapeutics.com | 11% |
| First.Last@pelotontherapeutics.com | 33% |
Pharmaceutical ManufacturingTexas, United States51-200 Employees
Peloton Therapeutics, Inc., is a clinical-stage biotechnology company that discovers and develops novel small molecule cancer therapies targeting unexploited molecular vulnerabilities. Peloton Therapeutics’ lead programs are small molecule inhibitors targeting hypoxia inducible factor-2α (HIF-2α), a transcription factor implicated in the development and progression of kidney and other cancers.
Company Overview
Media & News
Funding & FinancialsPeloton Therapeutics has raised a total of $640M of funding over 5 rounds. Their latest funding round was raised on Feb 20, 2019 in the amount of $150Mas a Series E.
Funding & FinancialsPeloton Therapeutics has raised a total of $640M of funding over 5 rounds. Their latest funding round was raised on Feb 20, 2019 in the amount of $150Mas a Series E.
1-888-653-2347 
support@leadiq.com